Aditxt, INC. (ADTX) — 10-Q Filings
All 10-Q filings from Aditxt, INC.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Aditxt's Q3 Net Loss Widens to $24.2M Amid Revenue Collapse, Evofem Impairment
— Nov 18, 2025 Risk: high
Aditxt, Inc. (ADTX) reported a significant net loss of $24.21 million for the three months ended September 30, 2025, a substantial increase from the $6.98 milli -
Aditxt's Revenue Plummets 98%, Net Loss Narrows Amid Cash Burn
— Aug 14, 2025 Risk: high
Aditxt, Inc. reported a net loss of $13,348,123 for the six months ended June 30, 2025, a significant improvement from the $22,492,573 net loss in the prior-yea -
Aditxt, Inc. Files Q1 2025 10-Q Report
— May 15, 2025 Risk: low
Aditxt, Inc. filed its 10-Q report for the quarterly period ended March 31, 2025. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in De
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX